Maitreya Medicare MAITREYA.NS · INR

Its shares trade on NSE under the ticker MAITREYA.NS. It has been listed since 7 November 2023. In the fiscal year to 31 March 2025, it reported revenue of ₹466.6m and net income of ₹18.7m. At that date it held total assets of ₹479.9m and shareholders' equity of ₹320.8m.

Maitreya Medicare Ltd is a IN-based company operating in Health Care Providers & Services industry. The company is headquartered in Surat, Gujarat. The company went IPO on 2023-11-07. Maitreya Medicare Limited is an India-based company, which operates a 125 bedded, multispecialty hospital. The company provides multi-disciplinary integrated healthcare services, with a focus on primary secondary and tertiary care. The company offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including cardiology, urology, oncology, laparoscopic surgery, neurology, neurosurgery, spine surgery, nephrology, including dialysis, gastroenterology, gastrointestinal surgery, cardiothoracic surgery, oncosurgery, orthopedic surgery, including joint replacements and arthroscopic surgeries, gynecology and high-risk obstetrics, hepatocellular billary surgery, and critical care medicine, among others. The firm's facility consists of a Cath lab with Ivus/FFR/Rota and 20-bed Intensive Care Unit (ICU) fully equipped with ECMO/CRRT ventilators and monitors. The firm's subsidiaries include Maitreya Hospital Private Limited and Maitreya Lifescience Private Limited.

Figures and description from our data supplier, not checked against the company's own report.

• Dr. Narendra TanwarChief Financial Officer, Managing Director, Executive Director, since 2019
• Ms. Payal MathurCompliance Officer, Company Secretary
• Mr. Vimalkumar PatelWhole Time Director, since 2019
• Mr. Pranav ThakerWhole Time Director, since 2019
• Mr. Hardik PatelIndependent Director
• Ms. Abha SuranaIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.